Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
The T2D polygenic score serves as an independent predictor of incident diabetes, particularly among individuals with lower distribution of traditional risk factors.
Authors
- Christian T. Ruff (ORCID: https://orcid.org/0000-0002-4712-3206)
- Frederick Kamanu (ORCID: https://orcid.org/0000-0001-7208-1047)
- Marc S. Sabatine (ORCID: https://orcid.org/0000-0002-0691-3359)
- Robert P. Giugliano (ORCID: https://orcid.org/0000-0003-4110-7675)
- Miriam S. Udler (ORCID: https://orcid.org/0000-0003-3824-9162)
- Filipe A. Moura (ORCID: https://orcid.org/0000-0001-8017-1675)
- Patrick T. Ellinor (ORCID: https://orcid.org/0000-0002-2067-0533)
- Nicholas Marston (ORCID: https://orcid.org/0000-0001-6164-4617)
- Stephen D. Wiviott
- Jose C. Florez
Institutions
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Massachusetts General Hospital (US)
- Thrombolysis in Myocardial Infarction Study Group (US)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1111/dom.16123
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- American Heart Association
- European Commission
- National Institutes of Health
- National Heart, Lung, and Blood Institute